Viraj R. Sanghvi - Concepedia

Concepedia

Author

Viraj R. Sanghvi

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

, Viraj R Sanghvi, Viraj R. Sanghvi, Viraj Sanghvi

53

Publications

1.5K

Citations

12

H-Index

38

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University École Polytechnique Fédérale de Lausanne Ghent University Hospital University of Lausanne

VR

About

Viraj R. Sanghvi is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, cell biology, and gene expression.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.1K
2	Engineering	2	2	45
3	Natural Sciences	1	1	34
4	Allergy	1	1	11
5	Biochemistry	1	1	150

Viraj R. Sanghvi

×

13

Publications

1.5K

Citations

11

H-Index

	Year	Citations
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer Andrew L. Wolfe, Kamini Singh, Philipp Drewe, Nature MedicineCancer Cell BiologyCancer GeneticsGene ExpressionCancer Biology	2014	617
Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells Michael Boice, Darin Salloum, Frédéric Mourcin, Cell Lymphoid NeoplasiaHvem Tumor SuppressorModified Car-t CellsT-regulatory CellImmunology	2016	241
The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia Joni Van der Meulen, Viraj R. Sanghvi, Konstantinos J. Mavrakis, Blood	2014	190
The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase Viraj R. Sanghvi, Josef Leibold, Marco Mina, Cell Reductive StressSignal TransductionSignaling PathwayBiochemistryNrf2 Depends	2019	150
The Cellular TAR RNA Binding Protein, TRBP, Promotes HIV-1 Replication Primarily by Inhibiting the Activation of Double-Stranded RNA-Dependent Kinase PKR Viraj R. Sanghvi, Laura F. Steel Journal of Virology	2011	64
Genetic and epigenetic inactivation of <i>SESTRIN1</i> controls mTORC1 and response to EZH2 inhibition in follicular lymphoma Elisa Oricchio, Natalya Katanayeva, Maria Donaldson Collier, Science Translational Medicine	2017	57
Characterization of a set of tumor suppressor microRNAs in T cell acute lymphoblastic leukemia Viraj R. Sanghvi, Konstantinos J. Mavrakis, Joni Van der Meulen, Science Signaling Few MirnasMixed-phenotype Acute LeukemiaImmunologyLymphoblastic LeukemiaTumor Suppressor Micrornas	2014	41
A Re-Examination of Global Suppression of RNA Interference by HIV-1 Viraj R. Sanghvi, Laura F. Steel PLoS ONE Viral ReplicationEngineeringImmunologyCellular Rnai PathwayHuman Retrovirus	2011	34
Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules Kamini Singh, Jianan Lin, Nicolas Lecomte, Cancer Research Molecular RegulationTumor BiologyDeadly CancerSignaling PathwayCancer Cell Biology	2021	34
NRF2 Activation Confers Resistance to eIF4A Inhibitors in Cancer Therapy Viraj R. Sanghvi, Prathibha Mohan, Kamini Singh, Cancers	2021	26

Page 1